Is a complete INBS research report available?

No complete published report is available for Intelligent Bio Solutions Inc. (INBS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Intelligent Bio Solutions Inc. (INBS)

NASDAQ: INBS · USD

$1.66

-0.06 (-3.5%)· Recorded snapshot

Market cap	5M
Revenue (ttm)	4.2M
Net income (ttm)	-12.4M
EPS (ttm)	-$8.44
Shares out	3M
Volume	10,258
Beta	4.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.2M
Net income (ttm): -12.4M
EPS (ttm): -$8.44
Market cap: 5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001725430
Company name	Intelligent Bio Solutions Inc.
Country	United States
Country code	US
CUSIP number	36151G709
Earnings date	2026-11-11
Earnings time	bmo
Employees	60
Employees change	5
Employees growth	9.09%
Enterprise value	$2.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	2016
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US36151G7097
Last 10-K release date	2026-08-19
Last earnings date	2026-08-19
Last refreshed	2026-10-28
Last stock split date	2025-12-16
Last stock split type	Reverse
Market cap	$5M
Market cap category	Nano-Cap
Next earnings date	2026-11-11
Options	No
Price	$1.66
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	INBS
U.S. state	New York
Website	https://ibs.inc

Metric

Value

Amount currency

USD

CIK code

0001725430

Company name

Intelligent Bio Solutions Inc.

Country

United States

Country code

CUSIP number

36151G709

Earnings date

2026-11-11

Earnings time

bmo

Employees

Employees change

Employees growth

9.09%

Enterprise value

$2.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

June

Founded

2016

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

US36151G7097

Last 10-K release date

2026-08-19

Last earnings date

2026-08-19

Last refreshed

2026-10-28

Last stock split date

2025-12-16

Last stock split type

Reverse

Market cap

$5M

Market cap category

Nano-Cap

Next earnings date

2026-11-11

Options

Price

$1.66

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

INBS

U.S. state

New York

Website

https://ibs.inc

Metric	Value
Earnings yield	-508.48%
EV/Sales	0.68x
FCF / EV yield	-417.79%
FCF yield	-231.46%
Forward EV/Sales	0.47x
Forward P/S	0.85x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.91x
P/S ratio	1.24x
Price / tangible book value	1.92x
Sector forward P/E	23.56x
Sector P/E	50.09x

Metric

Value

Earnings yield

-508.48%

EV/Sales

0.68x

FCF / EV yield

-417.79%

FCF yield

-231.46%

Forward EV/Sales

0.47x

Forward P/S

0.85x

Industry forward P/E

19.74x

Industry P/E

39.16x

P/B ratio

0.91x

P/S ratio

1.24x

Price / tangible book value

1.92x

Sector forward P/E

23.56x

Sector P/E

50.09x

Metric	Value
EBIT margin	-292.03%
EBITDA margin	-264.42%
Gross margin	48.63%
Operating margin	-292.03%
Pretax margin	-295.8%
Profit margin	-294.91%
Profit per employee	$-207,183
Revenue per employee	$70,253
ROA	-76.2%
ROA (5Y)	-53.14%
ROCE	-175.53%
ROE	-307.69%
ROE (5Y)	-191.61%
ROIC	-150.77%
SBC / revenue	4.63%

Metric

Value

EBIT margin

-292.03%

EBITDA margin

-264.42%

Gross margin

48.63%

Operating margin

-292.03%

Pretax margin

-295.8%

Profit margin

-294.91%

Profit per employee

$-207,183

Revenue per employee

$70,253

ROA

-76.2%

ROA (5Y)

-53.14%

ROCE

-175.53%

ROE

-307.69%

ROE (5Y)

-191.61%

ROIC

-150.77%

SBC / revenue

4.63%

Metric	Value
EPS growth quarters	4
EPS growth years	5
Gross profit growth	64.41%
Gross profit growth (Q)	59.9%
Gross profit growth 3Y	84.45%
Gross profit growth 5Y	0.69%
Net income growth years	0
Revenue growth	38.09%
Revenue growth (Q)	35.78%
Revenue growth (QoQ)	8.01%
Revenue growth 3Y	49.68%
Revenue growth 5Y	16.31%
Revenue growth quarters	5
Revenue growth years	4

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

64.41%

Gross profit growth (Q)

59.9%

Gross profit growth 3Y

84.45%

Gross profit growth 5Y

0.69%

Net income growth years

Revenue growth

38.09%

Revenue growth (Q)

35.78%

Revenue growth (QoQ)

8.01%

Revenue growth 3Y

49.68%

Revenue growth 5Y

16.31%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-125,731
Depreciation and amortization	$1.2M
EBIT	$-12.3M
EBITDA	$-11.1M
EPS	$-8.44
FCF per share	$-3.98
Financing cash flow	$15M
Free cash flow	$-12.1M
Free cash flow minus SBC	$-12.2M
Gross profit	$2M
Investing cash flow	$-85,573
Net cash flow	$3M
Net income	$-12.4M
Operating cash flow minus SBC	$-12.1M
Operating income	$-12.3M
Revenue	$4.2M
Stock-based compensation	$195,208

Metric

Value

Capital expenditures

$-125,731

Depreciation and amortization

$1.2M

EBIT

$-12.3M

EBITDA

$-11.1M

EPS

$-8.44

FCF per share

$-3.98

Financing cash flow

$15M

Free cash flow

$-12.1M

Free cash flow minus SBC

$-12.2M

Gross profit

$2M

Investing cash flow

$-85,573

Net cash flow

$3M

Net income

$-12.4M

Operating cash flow minus SBC

$-12.1M

Operating income

$-12.3M

Revenue

$4.2M

Stock-based compensation

$195,208

Metric	Value
Altman Z-Score	-10.81
Book value per share	$1.90
Debt / equity	0.34
Interest coverage	-1,146.57
Long-term assets	$4.8M
Long-term liabilities	$1.7M
Net cash (debt)	$2.3M
Net cash / market cap	44.6%
Net cash growth	168.85%
Net debt / equity	-0.44
Piotroski F-Score	4
Property, plant and equipment	$2M
Shareholders' equity	$5.3M
Tangible book value	$2.7M
Tangible book value per share	$0.93
Total assets	$11.9M
Total cash	$4.1M
Total debt	$1.8M
Total liabilities	$6.7M
WACC	20.81%

Metric

Value

Altman Z-Score

-10.81

Book value per share

$1.90

Debt / equity

0.34

Interest coverage

-1,146.57

Long-term assets

$4.8M

Long-term liabilities

$1.7M

Net cash (debt)

$2.3M

Net cash / market cap

44.6%

Net cash growth

168.85%

Net debt / equity

-0.44

Piotroski F-Score

Property, plant and equipment

$2M

Shareholders' equity

$5.3M

Tangible book value

$2.7M

Tangible book value per share

$0.93

Total assets

$11.9M

Total cash

$4.1M

Total debt

$1.8M

Total liabilities

$6.7M

WACC

20.81%

Metric	Value
Asset turnover	0.42
Current assets	$7.1M
Current liabilities	$4.9M
Current ratio	1.44
Inventory turnover	4.11
Net working capital	$-1.8M
Quick ratio	1.18
Working capital	$2.2M
Working capital turnover	8.82

Metric

Value

Asset turnover

0.42

Current assets

$7.1M

Current liabilities

$4.9M

Current ratio

1.44

Inventory turnover

4.11

Net working capital

$-1.8M

Quick ratio

1.18

Working capital

$2.2M

Working capital turnover

8.82

Metric	Value
Buyback yield / dilution	-179.27%
Dividend yield	0%
Shareholder yield	-179.27%

Metric

Value

Buyback yield / dilution

-179.27%

Dividend yield

Shareholder yield

-179.27%

Metric	Value
150-day SMA	$2.29
1D price change	-3.49%
1M price change	-2.35%
1M total return	-2.35%
1W price change	-4.05%
1W total return	-4.05%
1Y price change	-83.4%
1Y return CAGR	-83.42%
1Y total return	-83.4%
20-day SMA	$1.59
200-day SMA	$3.32
3M price change	-3.49%
3M total return	-3.49%
3Y price change	-93.54%
3Y return CAGR	-59.86%
3Y total return	-93.54%
50-day SMA	$1.92
50-day SMA vs 200-day SMA	50under200
52-week high	$24.90
52-week high date	2026-01-12
52-week low	$1.35
52-week low date	2026-10-14
5Y price change	-99.97%
5Y return CAGR	-79.83%
5Y total return	-99.97%
6M price change	-32.41%
6M total return	-32.42%
All-time high	$34,175.77
All-time high date	2020-12-23
All-time low	$1.35
All-time low date	2026-10-14
Average true range (ATR)	$0.12
Average volume	43.8K
Beta (1Y)	1.8
Beta (2Y)	1.42
Beta (5Y)	4.3
Change from 52-week high	-93.33%
Change from 52-week low	22.96%
Change from all-time high	-100%
Change from all-time low	22.96%
Change from open	0.61%
Day's gap	-4.07%
Dollar volume	$17,028
High price	$1.70
Low price	$1.65
Monthly RSI	22
Open price	$1.65
Position in 52-week range	20%
Premarket change	-6.42%
Premarket close	$1.72
Premarket price	$1.61
Premarket volume	430
Previous close	$1.72
Price vs 150-day SMA	-27.61%
Price vs 20-day SMA	4.21%
Price vs 200-day SMA	-49.95%
Price vs 50-day SMA	-13.32%
Relative volume	0.23
RSI	47.8
Sharpe ratio	-0.39
Sharpe ratio (3Y)	0.16
Sharpe ratio (5Y)	-0.09
Sortino ratio	-0.87
Sortino ratio (3Y)	0.43
Sortino ratio (5Y)	-0.18
Volume	10.3K
Weekly RSI	38.22
YTD price change	-82.58%
YTD total return	-82.58%

Metric

Value

150-day SMA

$2.29

1D price change

-3.49%

1M price change

-2.35%

1M total return

-2.35%

1W price change

-4.05%

1W total return

-4.05%

1Y price change

-83.4%

1Y return CAGR

-83.42%

1Y total return

-83.4%

20-day SMA

$1.59

200-day SMA

$3.32

3M price change

-3.49%

3M total return

-3.49%

3Y price change

-93.54%

3Y return CAGR

-59.86%

3Y total return

-93.54%

50-day SMA

$1.92

50-day SMA vs 200-day SMA

50under200

52-week high

$24.90

52-week high date

2026-01-12

52-week low

$1.35

52-week low date

2026-10-14

5Y price change

-99.97%

5Y return CAGR

-79.83%

5Y total return

-99.97%

6M price change

-32.41%

6M total return

-32.42%

All-time high

$34,175.77

All-time high date

2020-12-23

All-time low

$1.35

All-time low date

2026-10-14

Average true range (ATR)

$0.12

Average volume

43.8K

Beta (1Y)

1.8

Beta (2Y)

1.42

Beta (5Y)

4.3

Change from 52-week high

-93.33%

Change from 52-week low

22.96%

Change from all-time high

-100%

Change from all-time low

22.96%

Change from open

0.61%

Day's gap

-4.07%

Dollar volume

$17,028

High price

$1.70

Low price

$1.65

Monthly RSI

Open price

$1.65

Position in 52-week range

20%

Premarket change

-6.42%

Premarket close

$1.72

Premarket price

$1.61

Premarket volume

430

Previous close

$1.72

Price vs 150-day SMA

-27.61%

Price vs 20-day SMA

4.21%

Price vs 200-day SMA

-49.95%

Price vs 50-day SMA

-13.32%

Relative volume

0.23

RSI

47.8

Sharpe ratio

-0.39

Sharpe ratio (3Y)

0.16

Sharpe ratio (5Y)

-0.09

Sortino ratio

-0.87

Sortino ratio (3Y)

0.43

Sortino ratio (5Y)

-0.18

Volume

10.3K

Weekly RSI

38.22

YTD price change

-82.58%

YTD total return

-82.58%

Metric	Value
Float	2.9M
Float percentage	97.01%
Shares change (QoQ)	56.86%
Shares change (YoY)	179.27%
Shares held by insiders	2.99%
Shares held by institutions	7.07%
Shares outstanding	3M
Short % of float	1.98%
Short % of shares	1.93%
Short ratio	0.2 days

Metric

Value

Float

2.9M

Float percentage

97.01%

Shares change (QoQ)

56.86%

Shares change (YoY)

179.27%

Shares held by insiders

2.99%

Shares held by institutions

7.07%

Shares outstanding

Short % of float

1.98%

Short % of shares

1.93%

Short ratio

0.2 days

Intelligent Bio Solutions Inc. (INBS)

Price

Financial snapshot

Fair-value bridge

Latest news · INBS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INBS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INBS

Frequently asked questions